Glenmark Begins Phase 3 of Clinical Trials on Antiviral Favipiravir for Covid-19 Patients in India
As per the approved clinical trial protocol, 150 subjects with mild to moderate Covid-19 will be randomised in the study in a 1:1 ratio to Favipiravir with standard supportive care or standalone standard supportive care.